TIGIT expression was also documented on tumor cells, especially in cutaneous melanoma [39], choroidal melanoma [40], thyroid cancer [41], undifferentiated pleomorphic sarcoma [42], lung adenocarcinoma [43], and esophageal cancer [44]. This evidence concerns the gene TIGIT and lung adenocarcinoma.